|
|
|
|
| DLV03013a | 肝细胞性肝癌组织芯片，附病理分级、TNM和临床分期，23例/63点，替代BS03013 | | 点 数 | 63 | 例 数 | 23 | | 行 数 | 7 | 列 数 | 9 | | 点直径(mm) | 1.5 | 厚度(µm) | 5.0 | | 组织阵列类型 | 石蜡包埋 | 种 属 | 人类 | | QA/QC | H&E and IHC confirmed | | Applications | Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. | | Notes | 1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better. 2.Bake the slides for 30 minutes at 60℃ before the experiment; 3.Please choose a gentle repair method to avoid tissue detachment. |
|
|
| |
|
Legend:
|
|
Inflammati Malignant (II) Malignant (IIIA) Malignant (IIIC) NAT |
|
|
|
| |
| Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type | isBackUp |
| A1 | 1 | 38 | M | Liver | Hepatocholangiocarcinoma | 1 | T3N0M0 | IIIA | Malignant | N |
| A2 | 2 | 38 | M | Liver | Hepatocholangiocarcinoma | 1 | T3N0M0 | IIIA | Malignant | N |
| A3 | 3 | 38 | M | Liver | Hepatocholangiocarcinoma | 1 | T3N0M0 | IIIA | Malignant | N |
| A4 | 4 | 63 | F | Liver | Hepatocholangiocarcinoma | 1 | T2N0M0 | II | Malignant | N |
| A5 | 5 | 63 | F | Liver | Hepatocholangiocarcinoma | 1 | T2N0M0 | II | Malignant | N |
| A6 | 6 | 63 | F | Liver | Hepatocholangiocarcinoma | 1 | T2N0M0 | II | Malignant | N |
| A7 | 7 | 71 | M | Liver | Hepatocholangiocarcinoma | 1 | T3N0M0 | IIIA | Malignant | N |
| A8 | 8 | 71 | M | Liver | Hepatocholangiocarcinoma | 1 | T3N0M0 | IIIA | Malignant | N |
| A9 | 9 | 71 | M | Liver | Hepatocholangiocarcinoma | 1 | T3N0M0 | IIIA | Malignant | N |
| B1 | 10 | 50 | M | Liver | Hepatocholangiocarcinoma | 1 | T3N0M0 | IIIA | Malignant | N |
| B2 | 11 | 50 | M | Liver | Hepatocholangiocarcinoma | 1 | T3N0M0 | IIIA | Malignant | N |
| B3 | 12 | 50 | M | Liver | Hepatocholangiocarcinoma | 1 | T3N0M0 | IIIA | Malignant | N |
| B4 | 13 | 40 | M | Liver | Hepatocholangiocarcinoma | 2 | T2N0M0 | II | Malignant | N |
| B5 | 14 | 40 | M | Liver | Hepatocholangiocarcinoma | 2 | T2N0M0 | II | Malignant | N |
| B6 | 15 | 40 | M | Liver | Hepatocholangiocarcinoma | 2 | T2N0M0 | II | Malignant | N |
| B7 | 16 | 50 | M | Liver | Hepatocholangiocarcinoma | 2 | T2N0M0 | II | Malignant | N |
| B8 | 17 | 50 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant | N |
| B9 | 18 | 50 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant | N |
| C1 | 19 | 78 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant | N |
| C2 | 20 | 78 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant | N |
| C3 | 21 | 78 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant | N |
| C4 | 22 | 35 | M | Liver | Hepatocellular carcinoma | 2 | T3N0M0 | IIIA | Malignant | N |
| C5 | 23 | 35 | M | Liver | Hepatocellular carcinoma | 2 | T3N0M0 | IIIA | Malignant | N |
| C6 | 24 | 35 | M | Liver | Hepatocellular carcinoma (sparse) | 2 | T3N0M0 | IIIA | Malignant | N |
| C7 | 25 | 43 | F | Liver | Hepatocellular carcinoma | 2 | T3N0M0 | IIIA | Malignant | N |
| C8 | 26 | 43 | F | Liver | Hepatocellular carcinoma | 2 | T3N0M0 | IIIA | Malignant | N |
| C9 | 27 | 43 | F | Liver | Hepatocellular carcinoma | 2 | T3N0M0 | IIIA | Malignant | N |
| D1 | 28 | 36 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant | N |
| D2 | 29 | 36 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant | N |
| D3 | 30 | 36 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant | N |
| D4 | 31 | 52 | M | Liver | Hepatocellular carcinoma | 2 | T3N1M0 | IIIC | Malignant | N |
| D5 | 32 | 52 | M | Liver | Hepatocellular carcinoma with necrosis | 2 | T3N1M0 | IIIC | Malignant | N |
| D6 | 33 | 52 | M | Liver | Hepatocellular carcinoma with necrosis | 2 | T3N1M0 | IIIC | Malignant | N |
| D7 | 34 | 52 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant | N |
| D8 | 35 | 52 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant | N |
| D9 | 36 | 52 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant | N |
| E1 | 37 | 48 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant | N |
| E2 | 38 | 48 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant | N |
| E3 | 39 | 48 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant | N |
| E4 | 40 | 35 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant | N |
| E5 | 41 | 35 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant | N |
| E6 | 42 | 35 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant | N |
| E7 | 43 | 50 | M | Liver | Hepatocellular carcinoma | 2 | T3N0M0 | IIIA | Malignant | N |
| E8 | 44 | 50 | M | Liver | Hepatocellular carcinoma | 2 | T3N0M0 | IIIA | Malignant | N |
| E9 | 45 | 50 | M | Liver | Hepatocellular carcinoma | 2 | T3N0M0 | IIIA | Malignant | N |
| F1 | 46 | 56 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | IIIA | Malignant | N |
| F2 | 47 | 56 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | IIIA | Malignant | N |
| F3 | 48 | 56 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | IIIA | Malignant | N |
| F4 | 49 | 43 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | IIIA | Malignant | N |
| F5 | 50 | 43 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | IIIA | Malignant | N |
| F6 | 51 | 43 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | IIIA | Malignant | N |
| F7 | 52 | 48 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | IIIA | Malignant | N |
| F8 | 53 | 48 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | IIIA | Malignant | N |
| F9 | 54 | 48 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | IIIA | Malignant | N |
| G1 | 55 | 63 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | IIIA | Malignant | N |
| G2 | 56 | 63 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | IIIA | Malignant | N |
| G3 | 57 | 63 | M | Liver | Hepatocellular carcinoma | 3 | T3N0M0 | IIIA | Malignant | N |
| G4 | 58 | 57 | M | Liver | Hepatocellular carcinoma | 3 | T2N0M0 | II | Malignant | N |
| G5 | 59 | 57 | M | Liver | Hepatocellular carcinoma | 3 | T2N0M0 | II | Malignant | N |
| G6 | 60 | 57 | M | Liver | Hepatocellular carcinoma (sparse) | 3 | T2N0M0 | II | Malignant | N |
| G7 | 61 | 60 | M | Liver | Cancer adjacent normal liver tissue | - | - | - | NAT | N |
| G8 | 62 | 70 | M | Liver | Cancer adjacent normal liver tissue | - | - | - | NAT | N |
| G9 | 63 | 54 | F | Liver | Chronic hepatitis | - | - | - | Inflammati | N | | Tissue Marker |
|
|
